X-linked intellectual disability-monoamine oxidase A metabolism anomaly syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:3065
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

X-linked intellectual disability-monoamine oxidase A metabolism anomaly syndrome, also known as Brunner syndrome, is a rare genetic condition caused by mutations in the MAOA gene located on the X chromosome. This gene encodes monoamine oxidase A, an enzyme critical for the breakdown of neurotransmitters including serotonin, norepinephrine, and dopamine. When this enzyme is deficient or absent, these monoamines accumulate abnormally in the body, leading to neurological and behavioral disturbances. The syndrome primarily affects the central nervous system and is characterized by mild to borderline intellectual disability combined with prominent behavioral abnormalities. Key behavioral features include impulsive aggression, violent outbursts, arson, attempted rape, and other antisocial behaviors. Affected individuals may also exhibit sleep disturbances, night terrors, and stereotyped hand movements such as hand wringing or plucking. The condition predominantly affects males due to its X-linked recessive inheritance pattern, while carrier females are generally unaffected or mildly affected. Diagnosis is supported by biochemical findings showing markedly elevated urinary levels of monoamines and their metabolites, particularly elevated levels of serotonin, and can be confirmed through molecular genetic testing of the MAOA gene. There is currently no specific cure for this condition. Management is primarily supportive and symptomatic, focusing on behavioral interventions, structured environments, and in some cases pharmacological management of aggression and impulsivity. Genetic counseling is recommended for affected families.

Inheritance

X-linked recessive

Carried on the X chromosome; typically affects males more than females

Age of Onset

Childhood

Begins in childhood, roughly ages 1 to 12

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for X-linked intellectual disability-monoamine oxidase A metabolism anomaly syndrome.

View clinical trials →

No actively recruiting trials found for X-linked intellectual disability-monoamine oxidase A metabolism anomaly syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the X-linked intellectual disability-monoamine oxidase A metabolism anomaly syndrome community →

No specialists are currently listed for X-linked intellectual disability-monoamine oxidase A metabolism anomaly syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to X-linked intellectual disability-monoamine oxidase A metabolism anomaly syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open X-linked intellectual disability-monoamine oxidase A metabolism anomaly syndromeForum →

No community posts yet. Be the first to share your experience with X-linked intellectual disability-monoamine oxidase A metabolism anomaly syndrome.

Start the conversation →

Latest news about X-linked intellectual disability-monoamine oxidase A metabolism anomaly syndrome

No recent news articles for X-linked intellectual disability-monoamine oxidase A metabolism anomaly syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about X-linked intellectual disability-monoamine oxidase A metabolism anomaly syndrome

What is X-linked intellectual disability-monoamine oxidase A metabolism anomaly syndrome?

X-linked intellectual disability-monoamine oxidase A metabolism anomaly syndrome, also known as Brunner syndrome, is a rare genetic condition caused by mutations in the MAOA gene located on the X chromosome. This gene encodes monoamine oxidase A, an enzyme critical for the breakdown of neurotransmitters including serotonin, norepinephrine, and dopamine. When this enzyme is deficient or absent, these monoamines accumulate abnormally in the body, leading to neurological and behavioral disturbances. The syndrome primarily affects the central nervous system and is characterized by mild to borderl

How is X-linked intellectual disability-monoamine oxidase A metabolism anomaly syndrome inherited?

X-linked intellectual disability-monoamine oxidase A metabolism anomaly syndrome follows a x-linked recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does X-linked intellectual disability-monoamine oxidase A metabolism anomaly syndrome typically begin?

Typical onset of X-linked intellectual disability-monoamine oxidase A metabolism anomaly syndrome is childhood. Age of onset can vary across affected individuals.